You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

boceprevir

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Chronic Trial (Boceprevir, Peginterferon alfa-2b (PEG2b), Ribavirin (RBV))

Completed
Has Results
  • Hepatitis C, Chronic
  • Boceprevir
  • +3 more
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)

Completed
Has Results
  • Chronic Hepatitis C Genotype 1
  • Boceprevir
  • +3 more
  • (no location specified)
Jan 15, 2021

HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))

Completed
Has Results
  • HIV Infections
  • Hepatitis C
  • Pegylated-Interferon Alfa 2b (PEG-IFN)
  • +2 more
  • Birmingham, Alabama
  • +42 more
Nov 2, 2021

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Hepatitis C Trial in London (Sildenafil and Boceprevir)

Completed
Has Results
  • Hepatitis C
  • Sildenafil and Boceprevir
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Jun 6, 2019

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    HCV-TARGET- Hepatitis C Therapeutic Registry and Research

    Active, not recruiting
    • Hepatitis C
      • Phoenix, Arizona
      • +59 more
      Oct 5, 2022

      Hepatitis C, Chronic Trial (Boceprevir)

      Terminated
      Has Results
      • Hepatitis C, Chronic
      • Boceprevir
      • (no location specified)
      Aug 13, 2018

      Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)

      Completed
      Has Results
      • Hepatitis C
      • boceprevir
      • +2 more
      • (no location specified)
      Aug 6, 2018

      Thrombocytopenia, Hepatitis C Trial in Dallas (Eltrombopag)

      Terminated
      Has Results
      • Thrombocytopenia
      • Hepatitis C
      • Dallas, Texas
        UT Southwestern Medical Center
      Oct 30, 2019

      RIBAvirin Plasma COncentrations in Chronic Hepatitis C Infection

      Completed
      • HCV Coinfection
      • Hepatitis C
        • Nijmegen, Gelderland, Netherlands
          Radboud University Medical Centre
        Dec 4, 2020

        Hepatitis C, Chronic Trial in Kaohsiung (Stop trial intervention for boceprevir, PEG-IFN and RBV)

        Completed
        Has Results
        • Hepatitis C, Chronic
        • Stop trial intervention for boceprevir, PEG-IFN and RBV
        • Kaohsiung, Taiwan
          Hepatitis Center and Hepatobiliary Division, Department of Inter
        Mar 12, 2018

        Healthy Trial in Montréal (Maraviroc (5 days), Maraviroc and boceprevir (14 days))

        Completed
        • Healthy
        • Maraviroc (5 days)
        • Maraviroc and boceprevir (14 days)
        • Montréal, Quebec, Canada
          Centre Hospitalier de l'Université de Montréal
        Jan 24, 2018

        Impact of Antiviral Therapy on Gastroesophageal Varices.

        Completed
        • Chronic Hepatitis C
        • Cirrhosis
        • Pegylated interferon alfa-2a + Ribavirin
        • +6 more
        • (no location specified)
        May 18, 2018

        Thrombocytopaenia Trial in Baltimore (Eltrombopag, Boceprevir, Telaprevir)

        Completed
        • Thrombocytopaenia
        • Baltimore, Maryland
          GSK Investigational Site
        Nov 8, 2017

        Dual and Triple Therapies Based on Pegasys in Chronic Hepatitis

        Completed
        Has Results
        • Hepatitis C, Chronic
          • Afula, Israel
          • +20 more
          Nov 21, 2018

          Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

          Completed
          Has Results
          • Hepatitis C
          • Cryoglobulinemia
          • New York, New York
            Icahn School of Medicine at Mount Sinai
          Nov 23, 2020

          Hepatitis C Trial (boceprevir)

          Completed
          Has Results
          • Hepatitis C
          • boceprevir
          • (no location specified)
          Mar 9, 2017

          Hepatitis C Trial in Ottawa (ABT450r-ABT267-ABT333 +/- Ribavirin)

          Completed
          • Hepatitis C
          • ABT450r-ABT267-ABT333 +/- Ribavirin
          • Ottawa, Ontario, Canada
            The Ottawa Hospital, General Campus
          Aug 9, 2019

          Infection, Human Immunodeficiency Virus Trial in Austin (DTG, BCV, TVR)

          Completed
          • Infection, Human Immunodeficiency Virus
          • Austin, Texas
            GSK Investigational Site
          Mar 27, 2017

          Hepatitis C, Chronic, Cirrhosis Trial in Cleveland (Telaprevir, Boceprevir, Peg-IFN)

          Completed
          • Hepatitis C, Chronic
          • Cirrhosis
          • Cleveland, Ohio
            Louis Stokes Cleveland VA medical center
          Mar 13, 2017

          Hepatitis C, Chronic, HIV Trial in Vienna (Pegylated interferon alpha-2a, Ribavirin, Boceprevir)

          Completed
          Has Results
          • Hepatitis C, Chronic
          • HIV
          • Pegylated interferon alpha-2a
          • +2 more
          • Vienna, Austria
            Division of Gastroenterology and Hepatology, Department of Inter
          Feb 8, 2017

          Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)

          Withdrawn
          • Hepatitis C
          • boceprevir
          • +2 more
          • (no location specified)
          Mar 17, 2017

          Hepatitis C Trial in Beverly Hills, Baltimore (Alisporivir, Boceprevir, Peginterferon alfa-2a)

          Terminated
          Has Results
          • Hepatitis C
          • Beverly Hills, California
          • +1 more
          Nov 18, 2016

          Chronic Hepatitis C Trial (paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin)

          Completed
          • Chronic Hepatitis C
          • paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin
          • (no location specified)
          Oct 17, 2018